Literature DB >> 2545316

Genetic differences in susceptibility to a mixture of avian infectious bronchitis virus and Escherichia coli.

N Bumstead1, M B Huggins, J K Cook.   

Abstract

Two-week-old chickens of 9 inbred and partially inbred lines of chickens were challenged intranasally with a mixed infection consisting of a pool of virulent strains of infectious bronchitis virus and a pool of pathogenic strains of Escherichia coli. 2. Wide differences in mortality were observed in the different lines, ranging from 3% in a Brown Leghorn line to 87% in White Leghorn line 7(2). 3. Experiments involving challenge with E. coli alone or virus alone suggested that this variation reflected resistance to the virus rather than to E. coli. 4. Reciprocal F1 matings suggested these differences in mortality were not attributable to maternal effects and indicated that the inheritance of resistance was fully dominant. 5. The pattern of mortality in F2 and backcross progeny of matings was compatible with the inheritance of a dominant autosomal resistance gene and showed no evidence of association with the major histocompatibility complex.

Entities:  

Mesh:

Year:  1989        PMID: 2545316     DOI: 10.1080/00071668908417123

Source DB:  PubMed          Journal:  Br Poult Sci        ISSN: 0007-1668            Impact factor:   2.095


  14 in total

1.  Effect of in ovo bursectomy on the course of an infectious bronchitis virus infection in line C White Leghorn chickens.

Authors:  J K Cook; T F Davison; M B Huggins; P McLaughlan
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

Review 2.  Sexual reproduction as an adaptation to resist parasites (a review).

Authors:  W D Hamilton; R Axelrod; R Tanese
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

3.  Characterization of cellular and humoral immune responses after IBV infection in chicken lines differing in MBL serum concentration.

Authors:  Rikke Munkholm Kjærup; Tina S Dalgaard; Liselotte R Norup; Edin Hamzic; Poul Sørensen; Helle R Juul-Madsen
Journal:  Viral Immunol       Date:  2014-12       Impact factor: 2.257

4.  Comparison of the efficacies of three fluoroquinolone antimicrobial agents, given as continuous or pulsed-water medication, against Escherichia coli infection in chickens.

Authors:  B Charleston; J J Gate; I A Aitken; B Stephan; R Froyman
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

5.  The Role of Host Genetic Factors in Coronavirus Susceptibility: Review of Animal and Systematic Review of Human Literature.

Authors:  Marissa LoPresti; David B Beck; Priya Duggal; Derek A T Cummings; Benjamin D Solomon
Journal:  medRxiv       Date:  2020-06-03

Review 6.  Brief review of the chicken Major Histocompatibility Complex: the genes, their distribution on chromosome 16, and their contributions to disease resistance.

Authors:  Marcia M Miller; Robert L Taylor
Journal:  Poult Sci       Date:  2016-01-06       Impact factor: 3.352

7.  The Long Pentraxin PTX3 Is of Major Importance Among Acute Phase Proteins in Chickens.

Authors:  Nina B Burkhardt; Susanne Röll; Anke Staudt; Daniel Elleder; Sonja Härtle; Taiana Costa; Andreas Alber; Mark P Stevens; Lonneke Vervelde; Benjamin Schusser; Bernd Kaspers
Journal:  Front Immunol       Date:  2019-02-01       Impact factor: 7.561

8.  The infection of primary avian tracheal epithelial cells with infectious bronchitis virus.

Authors:  Ching-I Shen; Ching-Ho Wang; Jiunn-Wang Liao; Tien-Wang Hsu; Shu-Ming Kuo; Hong-Lin Su
Journal:  Vet Res       Date:  2009-10-01       Impact factor: 3.683

9.  Analysis of immune responses induced by avian pathogenic Escherichia coli infection in turkeys and their association with resistance to homologous re-challenge.

Authors:  Jean-Rémy Sadeyen; Pete Kaiser; Mark P Stevens; Francis Dziva
Journal:  Vet Res       Date:  2014-02-14       Impact factor: 3.683

10.  Infectious bronchitis virus: Immunopathogenesis of infection in the chicken.

Authors:  G D Raj; R C Jones
Journal:  Avian Pathol       Date:  1997       Impact factor: 3.378

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.